Article info

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
Free
  1. Correspondence to:
    Dr William J Sandborn
    Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; sandborn.william{at}mayo.edu
View Full Text

Citation

Sandborn WJ, Hanauer SB, Rutgeerts P, et al
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

Publication history

  • Accepted January 29, 2007
  • Revised January 25, 2007
  • First published February 13, 2007.
Online issue publication 
August 14, 2007

Article Versions

  • William Sandborn, Paul Rutgeerts, Douglas Wolf, and Remo Panaccione have served as consultants for Abbott Laboratories. William Sandborn, Stephen Hanauer, Paul Rutgeerts, and Remo Panaccione have participated in continuing medical education events supported by unrestricted educational grants from Abbott Laboratories. Jeffrey Kent, Barry Bittle, Ju Li, and Paul Pollack are Abbott employees.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.